One of the tests, InBios International’s SCoV-2 Ag Detect Rapid Self-Test, accurately diagnosed infections between 81.2 percent to 90.7 percent of the time. The other at-home test, Abbott’s BinaxNOW COVID-19 Ag Card, found similar results, according to the study published Aug. 14 in JAMA.
The research, which was conducted by researchers from the University of Washington in Seattle and the University of Nevada in Reno, also found “no significant differences” across different variants and subvariants. Together, the diagnostic specificity was 99.8 percent.
“Although more clinical studies are needed, the ongoing home-based rapid antigen testing programs may be an important intervention to reduce global SARS-CoV-2 transmission,” they wrote.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
